SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001185185-23-000887
Filing Date
2023-08-21
Accepted
2023-08-21 12:44:48
Documents
15
Period of Report
2023-08-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K igcpharma20230821_8k.htm   iXBRL 8-K 46175
2 EXHIBIT 99.1 ex_562902.htm EX-99.1 8620
7 igcpharma20230821_8kimg001.jpg GRAPHIC 4616
  Complete submission text file 0001185185-23-000887.txt   208953

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA igc-20230818.xsd EX-101.SCH 3206
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE igc-20230818_def.xml EX-101.DEF 10590
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE igc-20230818_lab.xml EX-101.LAB 19959
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igc-20230818_pre.xml EX-101.PRE 10950
9 EXTRACTED XBRL INSTANCE DOCUMENT igcpharma20230821_8k_htm.xml XML 2444
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

IRS No.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-32830 | Film No.: 231188304
SIC: 2834 Pharmaceutical Preparations